Purchases and Sales Made in Q4 2023 in Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT) during Q4 2023. The information is specifically focused on institutions that hold shares of Nuvectis Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
34KNew |
$267K - $401K
|
34K
$171K
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
28.4K+ 7.91% |
$223K - $335K
|
388K
$1.95M
|
|
|
Feb 16, 2024
Q4 2023
|
Gsa Capital Partners LLP
London, X0 |
BUY
|
- |
27.3KNew |
$214K - $322K
|
27.3K
$137K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
26.4K+ 103.94% |
$207K - $311K
|
51.8K
$260K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
25.7KNew |
$202K - $302K
|
25.7K
$129K
|
|
|
Jan 08, 2024
Q4 2023
|
Baldwin Brothers LLC
|
BUY
|
- |
25.7K+ 22.05% |
$201K - $302K
|
142K
$713K
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
22.8KNew |
$179K - $268K
|
22.8K
$114K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
19.4K+ 558.67% |
$153K - $229K
|
22.9K
$115K
|
|
|
Feb 12, 2024
Q4 2023
|
Edmond De Rothschild Holding S.A.
Chambesy, V8 |
BUY
|
- |
19.2KNew |
$150K - $226K
|
19.2K
$96.2K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
12.7K+ 124.7% |
$99.8K - $150K
|
22.9K
$115K
|
|
|
Feb 14, 2024
Q4 2023
|
State Street Corp
Boston, MA |
BUY
|
- |
10.2K+ 9.39% |
$79.7K - $120K
|
118K
$594K
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
- |
8.87K+ 638.23% |
$69.6K - $104K
|
10.3K
$51.5K
|
|
|
Feb 13, 2024
Q4 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
6.89K+ 12.59% |
$54.1K - $81.1K
|
61.6K
$309K
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
6.15K+ 453.47% |
$48.3K - $72.4K
|
7.51K
$37.7K
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
4.71K+ 2453.13% |
$37K - $55.5K
|
4.9K
$24.6K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
4.28K+ 113.45% |
$33.6K - $50.5K
|
8.06K
$40.5K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
3.15K+ 1.08% |
$24.7K - $37.1K
|
294K
$1.48M
|
|
|
Jan 30, 2024
Q4 2023
|
Strs Ohio
|
BUY
|
- |
2.3K+ 58.97% |
$18.1K - $27.1K
|
6.2K
$31.1K
|
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
1.99K+ 1.54% |
$15.7K - $23.5K
|
132K
$661K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
1.26K+ 115.72% |
$9.88K - $14.8K
|
2.35K
$11.8K
|
|
|
Feb 14, 2024
Q4 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
BUY
|
- |
1.21K+ 11.38% |
$9.53K - $14.3K
|
11.9K
$59.7K
|
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
BUY
|
- |
1.1K+ 22060.0% |
$8.66K - $13K
|
1.11K
$5.56K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
437+ 29.83% |
$3.43K - $5.15K
|
1.9K
$9.55K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2024
Q4 2023
|
American International Group, Inc.
New York, NY |
SELL
|
- |
-16- 0.43% |
$126 - $188
|
3.7K
$18.5K
|
|
|
Feb 06, 2024
Q4 2023
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-69- 6.64% |
$542 - $813
|
970
$4.87K
|
|
|
Feb 13, 2024
Q4 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-417- 25.41% |
$3.27K - $4.91K
|
1.22K
$6.14K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-6K- 82.45% |
$47.1K - $70.7K
|
1.28K
$6.42K
|
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-11.3K- 31.24% |
$88.5K - $133K
|
24.8K
$125K
|